Search

Home > Cell & Gene: The Podcast > A Stem Cell-Derived Treatment for T1D
Podcast: Cell & Gene: The Podcast
Episode:

A Stem Cell-Derived Treatment for T1D
Category: Science & Medicine
Duration: 00:27:40
Publish Date: 2022-08-18 08:00:00
Description:

Sernova Corp. is a clinical-stage regenerative therapies company currently focused on insulin-dependent diabetes. CEO and President, Philip Toleikis, Ph.D., details the company's on-going clinical trial to treat Type 1 diabetes (T1D) as well as the very real potential to progress from simply masking symptoms to having a functional cure for T1D. Toleikis also provides his take on the near-term future of regenerative medicine.
Total Play: 0